{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T20:29:31Z","timestamp":1787084971645,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ihj.2026.03.001","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T08:13:16Z","timestamp":1772784796000},"page":"179-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence and predictors of aspirin and clopidogrel resistance by light transmittance platelet aggregometry in stable coronary artery disease"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8744-2108","authenticated-orcid":false,"given":"Nirmal","family":"Ghati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Narang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hara Prasad","family":"Pati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwani Kumar","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aseem","family":"Basha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7329","key":"10.1016\/j.ihj.2026.03.001_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Collaboration","year":"2002","journal-title":"BMJ Br Med J (Clin Res Ed)"},{"issue":"24","key":"10.1016\/j.ihj.2026.03.001_bib2","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.jacc.2013.07.101","article-title":"Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding","volume":"62","author":"Tantry","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ihj.2026.03.001_bib3","first-page":"79","article-title":"Cardiovascular diseases in India compared with the United States","volume":"72","author":"Prabhakaran","year":"2018"},{"issue":"2","key":"10.1016\/j.ihj.2026.03.001_bib4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1160\/TH14-05-0449","article-title":"Platelet function testing in acute cardiac care - is there a role for prediction or prevention of stent thrombosis and bleeding?","volume":"113","author":"Aradi","year":"2015","journal-title":"Thromb Haemost"},{"issue":"24","key":"10.1016\/j.ihj.2026.03.001_bib5","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC guideline for the management of patients with Non-ST-Elevation acute coronary syndromes: a report of the American college of cardiology\/american heart association task force on practice guidelines","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ihj.2026.03.001_bib6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ihj.2026.03.001_bib7","first-page":"152","article-title":"Profile and prevalence of clopidogrel resistance in patients of acute coronary syndrome","volume":"59","author":"Kumar","year":"2007","journal-title":"Indian Heart J"},{"issue":"1","key":"10.1016\/j.ihj.2026.03.001_bib8","first-page":"68","article-title":"Dual antiplatelet drug resistance in patients with acute coronary syndrome","volume":"61","author":"Guha","year":"2009","journal-title":"Indian Heart J"},{"issue":"2","key":"10.1016\/j.ihj.2026.03.001_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4103\/2229-516X.117086","article-title":"Study of platelet aggregation in acute coronary syndrome with special reference to metabolic syndrome","volume":"3","author":"Paul","year":"2013","journal-title":"Int J Appl Basic Medi Res"},{"issue":"4","key":"10.1016\/j.ihj.2026.03.001_bib10","first-page":"348","article-title":"Antiplatelet drug resistance in patients with recurrent acute coronary syndrome undergoing conservative management","volume":"61","author":"Guha","year":"2009","journal-title":"Indian Heart J"},{"issue":"5","key":"10.1016\/j.ihj.2026.03.001_bib11","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ihj.2015.12.022","article-title":"Oral antiplatelet therapy and platelet inhibition: an experience from a tertiary care center","volume":"68","author":"Dalal","year":"2016","journal-title":"Indian Heart J"},{"key":"10.1016\/j.ihj.2026.03.001_bib12","first-page":"321","article-title":"Variability in platelet response to a single daily dose of 150 mg enteric coated aspirin in a high risk population","volume":"56","author":"Mardikar","year":"2008","journal-title":"J Assoc Phys India"},{"issue":"6","key":"10.1016\/j.ihj.2026.03.001_bib13","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/ijlh.12416","article-title":"Association of CYP2C19, CYP3A5 and GPIIb\/IIIa gene polymorphisms with Aspirin and Clopidogrel Resistance in a cohort of Indian patients with Coronary Artery Disease","volume":"37","author":"Arya","year":"2015","journal-title":"Int J Lab Hematol"},{"issue":"1","key":"10.1016\/j.ihj.2026.03.001_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ihj.2013.10.001","article-title":"CYP 450 2C19 polymorphisms in Indian patients with coronary artery disease","volume":"66","author":"Shetkar","year":"2014","journal-title":"Indian Heart J"},{"issue":"11","key":"10.1016\/j.ihj.2026.03.001_bib15","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1007\/s11033-014-3613-8","article-title":"Single nucleotide polymorphism of CYP3A5\u22173 contributes to clopidogrel resistance in coronary artery disease patients among Tamilian population","volume":"41","author":"Priyadharsini","year":"2014","journal-title":"Mol Biol Rep"},{"issue":"4","key":"10.1016\/j.ihj.2026.03.001_bib16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4103\/0022-3859.58927","article-title":"Aspirin resistance in Indian patients with coronary artery disease and cardiovascular events","volume":"55","author":"Thomson","year":"2009","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.ihj.2026.03.001_bib17","series-title":"Catheterization and Cardiovascular Interventions","article-title":"Prevalence of aspirin resistance in Asian-Indian patients with stable coronary artery disease","author":"Chadha","year":"2014"},{"issue":"4","key":"10.1016\/j.ihj.2026.03.001_bib18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/09537104.2012.693992","article-title":"Clopidogrel resistance in North Indian patients of coronary artery disease and lack of its association with platelet ADP receptors P2Y1 and P2Y12 gene polymorphisms","volume":"24","author":"Kar","year":"2013","journal-title":"Platelets"},{"issue":"6","key":"10.1016\/j.ihj.2026.03.001_bib19","first-page":"658","article-title":"Profile and prevalence of aspirin resistance in Indian patients with coronary artery disease","volume":"57","author":"Sadiq","year":"2005","journal-title":"Indian Heart J"},{"issue":"1","key":"10.1016\/j.ihj.2026.03.001_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/heartasia-2014-010568","article-title":"Aspirin and clopidogrel resistance using the cone and plate(let) analyser in Indian patients with coronary artery disease","volume":"6","author":"Koshy","year":"2014","journal-title":"Heart Asia"},{"issue":"4","key":"10.1016\/j.ihj.2026.03.001_bib21","article-title":"ACCF\/AHA Guideline for the management of ST-Elevation myocardial infarction","volume":"127","author":"O'Gara","year":"2013","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.ihj.2026.03.001_bib22","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1161\/CIR.0000000000000095","article-title":"ACC\/AHA\/AATS\/PCNA\/SCAI\/STS Focused Update of the Guideline for the diagnosis and management of patients with stable ischemic heart disease","volume":"130","author":"Fihn","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2026.03.001_bib23","series-title":"Antiplatelet Therapy in Cardiovascular Disease","first-page":"277","article-title":"Aspirin resistance","author":"Vaduganathan","year":"2014"},{"issue":"12","key":"10.1016\/j.ihj.2026.03.001_bib24","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.2337\/db07-0707","article-title":"The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study","volume":"56","author":"DiChiara","year":"2007","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.ihj.2026.03.001_bib25","first-page":"3264","article-title":"Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients","volume":"26","author":"Sacco","year":"2003","journal-title":"Resul Prim Preven Project (PPP) trial"},{"issue":"2","key":"10.1016\/j.ihj.2026.03.001_bib26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.thromres.2003.12.016","article-title":"Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)\u2014its relation to metabolic control","volume":"113","author":"Watala","year":"2004","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.ihj.2026.03.001_bib27","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/eurheartj\/ehi684","article-title":"Aspirin and clopidogrel resistance: an emerging clinical entity","volume":"27","author":"Wang","year":"2006","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.ihj.2026.03.001_bib28","first-page":"1245","article-title":"Is Aspirin Resistance a Real Problem in People With Type 2 Diabetes? Response to Sacco et al","volume":"27","author":"Drzewoski","year":"2004"},{"issue":"3","key":"10.1016\/j.ihj.2026.03.001_bib29","first-page":"289","article-title":"Prevalence and risk factors for aspirin and clopidogrel resistance in patients with coronary artery disease or ischemic cerebrovascular disease","volume":"39","author":"Kim","year":"2009","journal-title":"Ann Clin Lab Sci"},{"issue":"3","key":"10.1016\/j.ihj.2026.03.001_bib30","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.thromres.2006.08.012","article-title":"Clopidogrel resistance?","volume":"120","author":"Gurbel","year":"2007","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.ihj.2026.03.001_bib31","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1089\/gtmb.2013.0407","article-title":"ABCB1 C3435T polymorphism and the risk of coronary heart disease: a meta-analysis","volume":"18","author":"Jin","year":"2014","journal-title":"Genet Test Mol Biomark"},{"issue":"4","key":"10.1016\/j.ihj.2026.03.001_bib32","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1160\/TH09-05-0285","article-title":"The influence of clinical characteristics, laboratory and inflammatory markers on 'high on-treatment platelet reactivity' as measured with different platelet function tests","volume":"102","author":"Elsenberg","year":"2009","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.ihj.2026.03.001_bib33","first-page":"227","article-title":"Are P2Y12 reaction unit (PRU) and % inhibition index equivalent for the expression of P2Y12 inhibition by the VerifyNow assay? Role of haematocrit and haemoglobin levels","volume":"106","author":"Voisin","year":"2011","journal-title":"Thromb Haemost"},{"issue":"8","key":"10.1016\/j.ihj.2026.03.001_bib34","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.amjcard.2011.11.049","article-title":"Impact of anemia on platelet response to clopidogrel in patients undergoing percutaneous coronary stenting","volume":"109","author":"Toma","year":"2012","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.ihj.2026.03.001_bib35","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/0003319711406432","article-title":"Relationship between plasma inflammatory markers and platelet aggregation in patients with clopidogrel resistance after angioplasty","volume":"63","author":"Ge","year":"2012","journal-title":"Angiology"},{"issue":"14","key":"10.1016\/j.ihj.2026.03.001_bib36","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1161\/01.CIR.0000013777.21160.07","article-title":"Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events","volume":"105","author":"Eikelboom","year":"2002","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ihj.2026.03.001_bib37","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0735-1097(02)03014-0","article-title":"A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease","volume":"41","author":"Gum","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.ihj.2026.03.001_bib38","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jama.2011.290","article-title":"Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial","volume":"305","author":"Price","year":"2011","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ihj.2026.03.001_bib39","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ahj.2010.06.004","article-title":"Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis","volume":"160","author":"Aradi","year":"2010","journal-title":"Am Heart J"},{"issue":"25","key":"10.1016\/j.ihj.2026.03.001_bib40","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1161\/01.CIR.0000130846.46168.03","article-title":"Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction","volume":"109","author":"Matetzky","year":"2004","journal-title":"Circulation"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483226000325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483226000325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T20:04:12Z","timestamp":1787083452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483226000325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0019483226000325"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2026.03.001","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and predictors of aspirin and clopidogrel resistance by light transmittance platelet aggregometry in stable coronary artery disease","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2026.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Cardiological Society of India. Published by Elsevier, a division of RELX India, Pvt. Ltd.","name":"copyright","label":"Copyright"}]}}